Prion protein misfolding and disease

Current Opinion in Structural Biology

Volumn 19, Issue 1, 2009, Pages 14-22

  Moore, Roger A ^a   Taubner, Lara M ^a   Priola, Suzette A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PRION PROTEIN;

AMINO ACID SEQUENCE; BIOLOGY; HUMAN; INFORMATION; MODEL; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; REVIEW;

AMINO ACID SEQUENCE; AMYLOID; ANIMALS; HUMANS; MODELS, MOLECULAR; PRION DISEASES; PRIONS; PROTEIN FOLDING;

MAMMALIA;

EID: 60349128086     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2008.12.007     Document Type: Review

References (74)

1. Priola S.A., and Vorberg I. Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies. Mol Biotechnol 33 (2006) 71-88
2. Castilla J., Saa P., Hetz C., and Soto C. In vitro generation of infectious scrapie prions. Cell 121 (2005) 195-206. The first demonstration that infectious prion particles could be generated in vitro by mixing uninfected and prion-infected brain homogenates in serial rounds of dilution and sonication. This method is now widely termed protein misfolding cyclic amplification, or PMCA.
3. Deleault N.R., Harris B.T., Rees J.R., and Supattapone S. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci U S A 104 (2007) 9741-9746. This study demonstrated that prions could be formed without infectious PrP-res as a seed from a minimal set of components including native PrP-sen, lipid molecules, and a synthetic polyanion.
4. Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R., and Wuthrich K. NMR structure of the mouse prion protein domain PrP(121-231). Nature 382 (1996) 180-182. First NMR solution structure of the globular fold of PrP-sen.
5. Zahn R., Liu A., Luhrs T., Riek R., von Schroetter C., Garcia F.L., Billeter M., Calzolai L., Wider G., and Wuthrich K. NMR solution structure of human prion protein. Proc Natl Acad Sci U S A 97 (2000) 145-150
6. Garcia F.L., Zahn R., Riek R., and Wuthrich K. NMR structure of the bovine prion protein. Proc Natl Acad Sci U S A 97 (2000) 8334-8339
7. Wuthrich K., and Riek R. Three-dimensional structures of prion proteins. Adv Prot Chem 57 (2001) 55-82
8. Lysek D.A., Schorn C., Nivon L.G., Esteve-Moya V., Christen B., Calzolai L., von S.C., Fiorito F., Herrmann T., Guntert P., and Wuthrich K. Prion protein NMR structures of cats, dogs, pigs, and sheep. Proc Natl Acad Sci U S A 102 (2005) 640-645
9. Calzolai L., Lysek D.A., Perez D.R., Guntert P., and Wuthrich K. Prion protein NMR structures of chickens, turtles, and frogs. Proc Natl Acad Sci U S A 102 (2005) 651-655
10. Riek R., Hornemann S., Wider G., Glockshuber R., and Wuthrich K. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett 413 (1997) 282-288
11. Haire L.F., Whyte S.M., Vasisht N., Gill A.C., Verma C., Dodson E.J., Dodson G.G., and Bayley P.M. The crystal structure of the globular domain of sheep prion protein. J Mol Biol 336 (2004) 1175-1183
12. Knaus K.J., Morillas M., Swietnicki W., Malone M., Surewicz W.K., and Yee V.C. Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat Struct Biol 8 (2001) 770-774
13. Hornemann S., Schorn C., and Wuthrich K. NMR structure of the bovine prion protein isolated from healthy calf brains. EMBO Rep 5 (2004) 1159-1164. This work showed that the three-dimensional structure of natural mammalian PrP and genetically engineered recombinant PrP are essentially the same, thus providing validation to the majority of structural studies which must rely on recombinant PrP.
14. Scott M., Groth D., Foster D., Torchia M., Yang S.L., DeArmond S.J., and Prusiner S.B. Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell 73 (1993) 979-988
15. Scott M.R., Kohler R., Foster D., and Prusiner S.B. Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci 1 (1992) 986-997. First definitive mapping study showing that it was the central region of the PrP primary amino acid sequence that influenced the species-specific conversion of PrP-sen to PrP-res.
16. Priola S.A., and Chesebro B. A single hamster amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells. J Virol 69 (1995) 7754-7758. First demonstration that sequence homology at a single amino acid residue could determine whether or not conversion of PrP-sen to PrP-res was possible.
17. Priola S.A., Chabry J., and Chan K. Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155. J Virol 75 (2001) 4673-4680
18. Bossers A., Belt P.B.G.M., Raymond G.J., Caughey B., de Vries R., and Smits M.A. Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms. Proc Natl Acad Sci U S A 94 (1997) 4931-4936
19. Bossers A., de Vries R., and Smits M.A. Susceptibility of sheep for scrapie as assessed by in vitro conversion of nine naturally occurring variants of PrP. J Virol 74 (2000) 1407-1414
20. Raymond G.J., Hope J., Kocisko D.A., Priola S.A., Raymond L.D., Bossers A., Ironside J., Will R.G., Chen S.G., Petersen R.B., et al. Molecular assessment of the transmissibilities of BSE and scrapie to humans. Nature 388 (1997) 285-288
21. Goldmann W., Hunter N., Smith G., Foster J., and Hope J. PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie. J Gen Virol 75 (1994) 989-995
22. Palmer M.S., Dryden A.J., Hughes J.T., and Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352 (1991) 340-342
23. Hunter N., Foster J.D., Goldmann W., Stear M.J., Hope J., and Bostock C. Natural scrapie in a closed flock of Cheviot sheep occurs only in specific PrP genotypes. Arch Virol 141 (1996) 809-824
24. Vorberg I., Groschup M.H., Pfaff E., and Priola S.A. Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform. J Virol 77 (2003) 2003-2009
25. Gossert A.D., Bonjour S., Lysek D.A., Fiorito F., and Wuthrich K. Prion protein NMR structures of elk and of mouse/elk hybrids. Proc Natl Acad Sci U S A 102 (2005) 646-650
26. Christen B., Perez D.R., Hornemann S., and Wuthrich K. NMR structure of the bank vole prion protein at 20 degrees C contains a structured loop of residues 165-171. J Mol Biol 383 (2008) 306-312
27. Sigurdson C.J., and Aguzzi A. Chronic wasting disease. Biochim Biophys Acta 1772 (2007) 610-618
28. Supattapone S., Bosque P., Muramoto T., Wille H., Aagaard C., Peretz D., Nguyen H.O., Heinrich C., Torchia M., Safar J., et al. Prion protein of 106 residues creates an artificial transmission barrier for prion replication in transgenic mice. Cell 96 (1999) 869-878
29. Fischer M., Rulicke T., Raeber A., Sailer A., Moser M., Oesch B., Brandner S., Aguzzi A., and Weissmann C. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 15 (1996) 1255-1264
30. Vorberg I., Chan K., and Priola S.A. Deletion of beta-strand and alpha-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform. J Virol 75 (2001) 10024-10032
31. Lawson V.A., Priola S.A., Wehrly K., and Chesebro B. N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro. J Biol Chem 276 (2001) 35265-35271
32. 2+ coordination modes. J Am Chem Soc 129 (2007) 15440-15441
33. Moore R.A., Herzog C., Errett J., Kocisko D.A., Arnold K.M., Hayes S.F., and Priola S.A. Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation. Protein Sci 15 (2006) 609-619
34. Safar J., Wille H., Itri V., Groth D., Serban H., Torchia M., Cohen F.E., and Prusiner S.B. Eight prion strains have PrP(Sc) molecules with different conformations [see comments]. Nat Med 4 (1998) 1157-1165
35. Sigurdson C.J., Nilsson K.P., Hornemann S., Manco G., Polymenidou M., Schwarz P., Leclerc M., Hammarstrom P., Wuthrich K., and Aguzzi A. Prion strain discrimination using luminescent conjugated polymers. Nat Methods 4 (2007) 1023-1030
36. Merz P.A., Somerville R.A., Wisniewski H.M., and Iqbal K. Abnormal fibrils from scrapie-infected brain. Acta Neuropathol 54 (1981) 63-74. First transmission electron microscopy images of scrapie-associated fibrils. The images were obtained before it was known that PrP-res was a major constituent of the fibrils.
37. Han S., and Hill A.F. Analysis of PrP conformation using circular dichroism. Methods Mol Biol 459 (2008) 145-159
38. Caughey B.W., Dong A., Bhat K.S., Ernst D., Hayes S.F., and Caughey W.S. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30 (1991) 7672-7680. This study demonstrated that FTIR could be applied to the analysis of PrP-res aggregates.
39. Pan K.-M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E., and Prusiner S.B. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion protein. Proc Natl Acad Sci U S A 90 (1993) 10962-10966
40. Caughey B., Raymond G.J., and Bessen R.A. Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J Biol Chem 273 (1998) 32230-32235. The author demonstrated that FTIR could be used to differentiate β-sheet conformation of PrP-res strains providing support for the hypothesis that prion strains are conformation-based.
41. Spassov S., Beekes M., and Naumann D. Structural differences between TSEs strains investigated by FT-IR spectroscopy. Biochim Biophys Acta 1760 (2006) 1138-1149
42. Thomzig A., Spassov S., Friedrich M., Naumann D., and Beekes M. Discriminating scrapie and bovine spongiform encephalopathy isolates by infrared spectroscopy of pathological prion protein. J Biol Chem 279 (2004) 33847-33854
43. Chiti F., and Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75 (2006) 333-366. Extensive review article for further reading on the role of amyloid in human disease.
44. Nelson R., and Eisenberg D. Structural models of amyloid-like fibrils. Adv Protein Chem 73 (2006) 235-282
45. Tycko R. Characterization of amyloid structures at the molecular level by solid state nuclear magnetic resonance spectroscopy. Methods Enzymol 413 (2006) 103-122
46. Nelson R., and Eisenberg D. Recent atomic models of amyloid fibril structure. Curr Opin Struct Biol 16 (2006) 260-265
47. Sawaya M.R., Sambashivan S., Nelson R., Ivanova M.I., Sievers S.A., Apostol M.I., Thompson M.J., Balbirnie M., Wiltzius J.J., McFarlane H.T., et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447 (2007) 453-457. The first fully objective atomic model of the interface between β-strands of amyloid-like fibrils.
48. Wiltzius J.J., Sievers S.A., Sawaya M.R., Cascio D., Popov D., Riekel C., and Eisenberg D. Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin). Protein Sci 17 (2008) 1467-1474
49. Ghetti B., Piccardo P., Spillantini M.G., Ichimiya Y., Porro M., Perini F., Kitamoto T., Tateishi J., Seiler C., Frangione B., et al. Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci U S A 93 (1996) 744-748
50. Kundu B., Maiti N.R., Jones E.M., Surewicz K.A., Vanik D.L., and Surewicz W.K. Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation. Proc Natl Acad Sci U S A 100 (2003) 12069-12074
51. Moore R.A., Hayes S.F., Fischer E.R., and Priola S.A. Amyloid formation via supramolecular peptide assemblies. Biochemistry 46 (2007) 7079-7087
52. Surewicz W.K., Jones E.M., and Apetri A.C. The emerging principles of mammalian prion propagation and transmissibility barriers: insight from studies in vitro. Acc Chem Res 39 (2006) 654-662
53. Breydo L., Makarava N., and Baskakov I.V. Methods for conversion of prion protein into amyloid fibrils. Methods Mol Biol 459 (2008) 105-115
54. Luhrs T., Zahn R., and Wuthrich K. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions. J Mol Biol 357 (2006) 833-841
55. Leffers K.W., Wille H., Stohr J., Junger E., Prusiner S.B., and Riesner D. Assembly of natural and recombinant prion protein into fibrils. Biol Chem 386 (2005) 569-580
56. Tattum M.H., Cohen-Krausz S., Thumanu K., Wharton C.W., Khalili-Shirazi A., Jackson G.S., Orlova E.V., Collinge J., Clarke A.R., and Saibil H.R. Elongated oligomers assemble into mammalian PrP amyloid fibrils. J Mol Biol 357 (2006) 975-985
57. Lee S., and Eisenberg D. Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process. Nat Struct Biol 10 (2003) 725-730
58. Makarava N., Lee C.I., Ostapchenko V.G., and Baskakov I.V. Highly promiscuous nature of prion polymerization. J Biol Chem 282 (2007) 36704-36713
59. Hill A.F., Antoniou M., and Collinge J. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J Gen Virol 80 (1999) 11-14
60. Legname G., Baskakov I.V., Nguyen H.O., Riesner D., Cohen F.E., DeArmond S.J., and Prusiner S.B. Synthetic mammalian prions. Science 305 (2004) 673-676. This study reported that amyloid-like fibrils of recombinant mouse PrP89-230 generated in vitro could initiate prion disease in transgenic mice overexpressing the same PrP sequence.
61. Lu X., Wintrode P.L., and Surewicz W.K. Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange. Proc Natl Acad Sci U S A 104 (2007) 1510-1515
62. Cobb N.J., Sonnichsen F.D., McHaourab H., and Surewicz W.K. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proc Natl Acad Sci U S A 104 (2007) 18946-18951. Model of r-PrP-res based upon site-directed spin labeling with EPR spectroscopy. Demonstrated that the core of full-length amyloid-like PrP fibrils maps to C-terminal residues 160-220, forming single-molecule layers with parallel, in-register alignment of β-strands.
63. Kocisko D.A., Lansbury Jr. P.T., and Caughey B. Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain. Biochemistry 35 (1996) 13434-13442
64. Atarashi R., Moore R.A., Sim V.L., Hughson A.G., Dorward D.W., Onwubiko H.A., Priola S.A., and Caughey B. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 4 (2007) 645-650. This study demonstrated that PrP-sen could be used to detect minute amounts of PrP-res and that the resulting r-PrP-res could acquire a conformation more closely resembling that of the PrP-res seed.
65. Stohr J., Weinmann N., Wille H., Kaimann T., Nagel-Steger L., Birkmann E., Panza G., Prusiner S.B., Eigen M., and Riesner D. Mechanisms of prion protein assembly into amyloid. Proc Natl Acad Sci U S A 105 (2008) 2409-2414
66. Atarashi R., Wilham J.M., Christensen L., Hughson A.G., Moore R.A., Johnson L.M., Onwubiko H.A., Priola S.A., and Caughey B. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods 5 (2008) 211-212
67. Demarco M.L., and Daggett V. From conversion to aggregation: protofibril formation of the prion protein. Proc Natl Acad Sci U S A 101 (2004) 2293-2298. Model of hamster PrP-res based upon molecular dynamics simulations.
68. Govaerts C., Wille H., Prusiner S.B., and Cohen F.E. Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci U S A 101 (2004) 8342-8347. Model of PrP-res based upon threading.
69. Bowie J.U., Luthy R., and Eisenberg D. A method to identify protein sequences that fold into a known three-dimensional structure. Science 253 (1991) 164-170
70. Wille H., Michelitsch M.D., Guenebaut V., Supattapone S., Serban A., Cohen F.E., Agard D.A., and Prusiner S.B. Structural studies of the scrapie prion protein by electron crystallography. Proc Natl Acad Sci U S A 99 (2002) 3563-3568. Construction of low-resolution models of PrP-res structure based upon electron microscopy experiments.
71. Demarco M.L., Silveira J., Caughey B., and Daggett V. Structural properties of prion protein protofibrils and fibrils: an experimental assessment of atomic models. Biochemistry 45 (2006) 15573-15582
72. Peretz D., Williamson R.A., Matsunaga Y., Serban H., Pinilla C., Bastidas R.B., Rozenshteyn R., James T.L., Houghten R.A., Cohen F.E., et al. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J Mol Biol 273 (1997) 614-622
73. DeLano W.L. The PyMOL Molecular Graphics System (2008), DeLano Scientific, Palo Alto, CA, USA. http://www.pymol.org/ http://www.pymol.org
74. Garnier J., Osguthorpe D.J., and Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol 120 (1978) 97-120